27 related articles for article (PubMed ID: 14619463)
1. Immune System Effects on Breast Cancer.
Amens JN; Bahçecioglu G; Zorlutuna P
Cell Mol Bioeng; 2021 Aug; 14(4):279-292. PubMed ID: 34295441
[TBL] [Abstract][Full Text] [Related]
2. [Intrapleural administration with OK-432 and cultured autologous pleural effusion lymphocytes for breast cancer patients with malignant pleural effusions: analysis of 84 patients over a 14-year period].
Kan N
Gan To Kagaku Ryoho; 1999 Oct; 26(12):1796-800. PubMed ID: 10560397
[TBL] [Abstract][Full Text] [Related]
3. Combined immunotherapy with intracavital injection of activated lymphocytes, monocyte-derived dendritic cells and low-dose OK-432 in patients with malignant effusion.
Morisaki T; Matsumoto K; Kuroki H; Kubo M; Baba E; Onishi H; Tasaki A; Nakamura M; Inaba S; Katano M
Anticancer Res; 2003; 23(6a):4459-65. PubMed ID: 14666734
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic and life-prolonging effect of intrapleural injection with a streptococcal preparation, OK-432, and IL2-cultured effusion lymphocytes to breast cancer patients with malignant pleural effusion.
Hori T; Mise K; Kan N; Okino T; Satoh K; Yamasaki S; Teramura Y; Harada T; Ohgaki K; Kodama H
Biotherapy; 1992; 5(1):21-9. PubMed ID: 1389900
[TBL] [Abstract][Full Text] [Related]
5. [Intrapleural treatment of breast cancer patients with pleural effusions: an analysis of 13 institutes in Kyoto and Shiga Prefectures. Kyoto and Shiga Breast Cancer Study Group].
Kan N; Kodama H; Hori T; Takenaka A; Yasumura T; Kato H; Ogawa H; Ohsumi K; Kudo N; Mukaihara S
Gan To Kagaku Ryoho; 1992 Aug; 19(10 Suppl):1632-5. PubMed ID: 1530322
[TBL] [Abstract][Full Text] [Related]
6. [Transarterial immuno-chemotherapy including adoptive transfer of autologous cultured lymphocytes for stage IV breast cancer patients with locally-advanced tumor].
Kan N; Harada T; Kodama H; Ichinose Y; Moriguchi Y; Sugie T; Li L; Sato K; Imamura M
Gan To Kagaku Ryoho; 1993 Aug; 20(11):1593-6. PubMed ID: 8373227
[TBL] [Abstract][Full Text] [Related]
7. [Analysis of 5-year survival among breast cancer patients with malignant pleural effusion receiving intrapleural OK-432 followed by adoptive transfer with cultured effusion lymphocytes].
Kan N
Gan To Kagaku Ryoho; 2003 Oct; 30(11):1559-61. PubMed ID: 14619463
[TBL] [Abstract][Full Text] [Related]
8. [Immunotherapy of gastric cancer].
Kan N; Ohgaki K; Okino T; Nakanishi M; Nio Y; Inoue K; Tobe T
Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-1):755-62. PubMed ID: 3291771
[TBL] [Abstract][Full Text] [Related]
9. Adoptive immunotherapy of advanced solid tumors: an eight year clinical experience.
Semino C; Martini L; Queirolo P; Cangemi G; Costa R; Alloisio A; Ferlazzo G; Sertoli MR; Reali UM; Ratto GB; Melioli G
Anticancer Res; 1999; 19(6C):5645-9. PubMed ID: 10697634
[TBL] [Abstract][Full Text] [Related]
10. Breast cancer immunotherapy.
Zhou J; Zhong Y
Cell Mol Immunol; 2004 Aug; 1(4):247-55. PubMed ID: 16225767
[TBL] [Abstract][Full Text] [Related]
11. 259 Patients with DCIS of the breast applying USC/Van Nuys prognostic index: a retrospective review with long term follow up.
Di Saverio S; Catena F; Santini D; Ansaloni L; Fogacci T; Mignani S; Leone A; Gazzotti F; Gagliardi S; De Cataldis A; Taffurelli M
Breast Cancer Res Treat; 2008 Jun; 109(3):405-16. PubMed ID: 17687650
[TBL] [Abstract][Full Text] [Related]
12. Diagnosis and management of malignant pleural effusions.
Heffner JE
Respirology; 2008 Jan; 13(1):5-20. PubMed ID: 18197908
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
